Abstract:Aromadendrin and taxifolin are two flavanonols (derived from the precursor naringenin) displaying diverse beneficial properties for humans. The carbon skeleton of these flavonoids may be transformed by the human gastrointestinal microbiota into other compounds, like auronols, which exert different and interesting biological activities. While research in flavonoids has become a certainly extensive field, studies about auronols are still scarce. In this work, different versions of the key plant enzyme for flavanonols biosynthesis, The flavanone 3-hydroxylase (F3H), has been screened for selecting the best one for the de novo production of these compounds in the bacterial factory Streptomyces albidoflavus UO-FLAV-004-NAR, a naringenin overproducer strain. This screening has rendered 2.6 μg/L of aromadendrin and 2.1 mg/L of taxifolin final production titers. Finally, the expression of the chalcone isomerase (CHI) from the gut bacterium Eubacterium ramulus has rendered a direct conversion (after feeding experiments) of 38.1% of (+)-aromadendrin into maesopsin and 74.6% of (+)-taxifolin into alphitonin. Moreover, de novo heterologous biosynthesis of 1.9 mg/L of alphitonin was accomplished by means of a co-culture strategy of a taxifolin producer S. albidoflavus and a CHI-expressing Escherichia coli, after the observation of the high instability of alphitonin in the culture medium. This study addresses the significance of culture time optimization and selection of appropriate enzymes depending on the desired final product. To our knowledge, this is the first time that alphitonin de novo production has been accomplished.

Transformation of Aucubin to New Pyridine Monoterpene Alkaloids, Aucubinines A and B, by Human Intestinal Bacteria

A Concise Synthesis of Monoterpene Pyridine Alkaloid Aucubinine B

Isolation of a Human Intestinal Bacterium Capable of Transforming Barbaloin to Aloe-Emodin Anthrone<sup>1</sup>

Metabolism Of Barbaloin By Intestinal Bacteria .2. Isolation Of A Human Intestinal Bacterium Capable Of Transforming Barbaloin To Aloe-Emodin Anthrone

Biotransformation of (-)-cubebin by Aspergillus spp. into (-)-hinokinin and (-)-parabenzlactone, and their evaluation against oral pathogenic bacteria

Microbial Transformation of Bufotalin by Alternaria Alternata As 3.4578

Non-enzymatic Transformation of Aflatoxin B1 by Pseudomonas geniculata m29

Microbial transformation of cinobufagin by Syncephalastrum racemosum.

Novel Antimicrobial Indolepyrazines A and B from the Marine-Associated Acinetobacter Sp. ZZ1275

MICROBIAL TRANSFORMATION OF TAXOL BY PSEUDOMONAS AERUGINOSA AS 1.860

Induction of New Metabolites from the Endophytic Fungus Bionectria Sp. Through Bacterial Co-Culture.

Harpagometabolins I And Ii, Two New Metabolites From Harpagoside By Human Intestinal Bacteria

Microbial transformation of alantolactone by Mucor polymorphosporus.

[Microbial Transformation of Sinenxan A, a Rich Constituent in Callus Cultures of Taxus].

Microbial transformation of three bufadienolides by Penicillium aurantigriseum and its application for metabolite identification in rat

Biotransformation of arenobufagin and cinobufotalin by Alternaria alternata

Optimization of flavanonols heterologous biosynthesis in Streptomyces albidoflavus, and generation of auronols

Microbial Transformation of Azorellane and Mulinane Diterpenoids

Gut Bacteria Involved in Ellagic Acid Metabolism To Yield Human Urolithin Metabotypes Revealed

Microbial hydroxylation of cinobufagin by Mucor spinosus.

Microbial Transformation of Yakuchinone A and Cytotoxicity Evaluation of Its Metabolites